Vycor Medical, Inc.
VYCO
$0.07
$0.00-0.29%
OTC PK
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 9.98% | -18.86% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 9.98% | -18.86% | |||
| Cost of Revenue | 2.33% | 31.66% | |||
| Gross Profit | 11.87% | -25.78% | |||
| SG&A Expenses | -11.65% | -11.85% | |||
| Depreciation & Amortization | -6.04% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -8.98% | -5.88% | |||
| Operating Income | 225.48% | -213.71% | |||
| Income Before Tax | 132.21% | -1,348.00% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 132.21% | -1,348.00% | |||
| Earnings from Discontinued Operations | 100.00% | -200.00% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 132.06% | -1,379.59% | |||
| EBIT | 225.48% | -213.71% | |||
| EBITDA | 401.47% | -142.50% | |||
| EPS Basic | -126.32% | 59.57% | |||
| Normalized Basic EPS | 133.33% | -1,300.00% | |||
| EPS Diluted | -126.32% | 59.57% | |||
| Normalized Diluted EPS | 133.33% | -1,300.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||